GLUE
Price
$6.53
Change
-$0.36 (-5.22%)
Updated
Jan 7, 04:59 PM (EDT)
65 days until earnings call
MGTX
Price
$6.35
Change
+$0.01 (+0.16%)
Updated
Jan 7, 04:59 PM (EDT)
64 days until earnings call
Ad is loading...

GLUE vs MGTX

Header iconGLUE vs MGTX Comparison
Open Charts GLUE vs MGTXBanner chart's image
Monte Rosa Therapeutics
Price$6.53
Change-$0.36 (-5.22%)
Volume$19.7K
CapitalizationN/A
MeiraGTx Holdings
Price$6.35
Change+$0.01 (+0.16%)
Volume$4.66K
CapitalizationN/A
GLUE vs MGTX Comparison Chart
Loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLUE vs. MGTX commentary
Jan 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Buy and MGTX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 08, 2025
Stock price -- (GLUE: $6.89 vs. MGTX: $6.34)
Brand notoriety: GLUE and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 42% vs. MGTX: 75%
Market capitalization -- GLUE: $400.87M vs. MGTX: $495.49M
GLUE [@Biotechnology] is valued at $400.87M. MGTX’s [@Biotechnology] market capitalization is $495.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $382.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 0 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • GLUE’s FA Score: 0 green, 5 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, GLUE is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 4 TA indicator(s) are bullish while MGTX’s TA Score has 4 bullish TA indicator(s).

  • GLUE’s TA Score: 4 bullish, 6 bearish.
  • MGTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MGTX is a better buy in the short-term than GLUE.

Price Growth

GLUE (@Biotechnology) experienced а -1.85% price change this week, while MGTX (@Biotechnology) price change was +7.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.08%. For the same industry, the average monthly price growth was +1.56%, and the average quarterly price growth was +4.32%.

Reported Earning Dates

GLUE is expected to report earnings on May 08, 2025.

MGTX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+6.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($495M) has a higher market cap than GLUE($401M). MGTX YTD gains are higher at: 4.105 vs. GLUE (-0.720). MGTX has higher annual earnings (EBITDA): -61.2M vs. GLUE (-121.07M). GLUE has more cash in the bank: 242M vs. MGTX (123M). GLUE has less debt than MGTX: GLUE (43.7M) vs MGTX (86.7M). GLUE has higher revenues than MGTX: GLUE (15M) vs MGTX (13.9M).
GLUEMGTXGLUE / MGTX
Capitalization401M495M81%
EBITDA-121.07M-61.2M198%
Gain YTD-0.7204.105-18%
P/E RatioN/AN/A-
Revenue15M13.9M108%
Total Cash242M123M197%
Total Debt43.7M86.7M50%
FUNDAMENTALS RATINGS
MGTX: Fundamental Ratings
MGTX
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLUEMGTX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 5 days ago
87%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 27 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
86%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRJDX46.860.70
+1.52%
PGIM Jennison Global Opportunities R4
JIHCX16.120.13
+0.81%
JPMorgan International Hedged Equity C
MSRFX16.150.01
+0.06%
Morgan Stanley Inst Next Gen Em Mkts R6
GLPSX39.34N/A
N/A
Goldman Sachs MLP Energy Infras R6
TVLCX11.83-0.01
-0.08%
Touchstone Value C

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with RXRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-3.91%
RXRX - GLUE
49%
Loosely correlated
+1.92%
CRSP - GLUE
44%
Loosely correlated
+3.44%
MGTX - GLUE
43%
Loosely correlated
-1.25%
BEAM - GLUE
42%
Loosely correlated
+3.86%
CRBU - GLUE
42%
Loosely correlated
+9.30%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with NTLA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
-1.25%
NTLA - MGTX
56%
Loosely correlated
+5.52%
BEAM - MGTX
54%
Loosely correlated
+3.86%
ABOS - MGTX
51%
Loosely correlated
-2.63%
AURA - MGTX
50%
Loosely correlated
-2.72%
CRSP - MGTX
50%
Loosely correlated
+3.44%
More